Hanna Fues Wahl (H Fues Wahl)

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 3

Top Topics

Chronic Myeloid Leukemia

Cross Sectional

Machine Learning

Epidermal Growth Factor Receptor

Top Venues

Human vaccines & immunotherapeutics

Acta oncologica (Stockholm, Sweden)

This page only lists publications with an associated author ORCID identifier.

Publications

Goran Bencina, Hanna Fues Wahl, Eleana Tsoumani, Stina Salomonsson
Recommendations and Health Technology Assessment (HTA) landscape evaluation for pediatric pneumococcal conjugate vaccines (PCV) in Europe: A systematic literature review. Human vaccines & immunotherapeutics 18 (5) (2022)
Rosa Lauppe, Fredrik O L Nilsson, Hanna Fues Wahl, Mathias Lilja, Anders Vikström, Sandra T Asanin
Use of ALK-tyrosine kinase inhibitors (ALK TKI) in clinical practice, overall survival, and treatment duration - a Swedish nationwide retrospective study. Acta oncologica (Stockholm, Sweden) 61 (11) (2022)
Hanna Fues Wahl, B Wikman Erlandson, C Sahlin, M Nyaku, Goran Bencina
Analysis of vaccine messages on social media (Twitter) in Scandinavia. Human vaccines & immunotherapeutics 18 (1) (2022)